According to the Legislative Budget Board (LBB), HB 130 will have no significant fiscal implications for the State of Texas. The bill's requirements—such as requiring annual compliance certifications from medical facilities, companies, research organizations, and nonprofits, and granting enforcement authority to the Attorney General—are expected to generate only minor administrative costs, which agencies can absorb within existing resources.

Additionally, any new revenue generated from civil penalties for violations (up to $10,000 per violation) is projected to be insignificant. The fiscal note assumes that the number of violations detected and successfully prosecuted would be limited, thus not resulting in a substantial fiscal impact either on the state treasury or through increased litigation costs.

For local governments, no significant fiscal impact is anticipated either. The bill's obligations primarily affect private and nonprofit entities operating in the genome sequencing field, not local governmental bodies. Moreover, the courts’ potential workload from private causes of action under the bill is expected to be minimal and manageable without additional resources.

HB 130 represents a focused, proactive effort to protect Texans' most sensitive personal information — their genetic data — from access, use, or exploitation by foreign adversaries. While the bill imposes a regulatory requirement on a narrow class of organizations (those handling genome sequencing), the burden is modest and justified by compelling national security, privacy, and sovereignty concerns.

The bill does not increase the size of government in a significant way, nor does it impose a cost on taxpayers. The enhanced oversight by the Attorney General’s Office is targeted and enforceable through civil penalties and private causes of action, not new agencies or funding. Concerns about state overreach are valid, but well mitigated by the bill’s scope and structure.

Although individuals do choose to share their genetic data, HB 130 addresses a unique and modern challenge: even voluntarily shared data can be exploited at scale by foreign powers with no obligation to uphold U.S. laws, ethics, or transparency. In this case, limited, defensive regulation supports liberty rather than undermining it.

This bill affirms the state's duty to safeguard its citizens from hostile actors while respecting the free market, individual responsibility, and due process. As such, Texas Policy Research recommends that lawmakers vote YES on HB 130.

• Individual Liberty: The bill enhances individual liberty by protecting the genetic information of Texans from access, analysis, or exploitation by foreign adversaries. It recognizes that genetic data is intensely personal, and securing it defends a citizen's right to privacy and bodily autonomy. Although individuals voluntarily share their data, the bill acts to ensure that their most sensitive information cannot be weaponized without their knowledge or consent, thereby strengthening liberty protections in a modern digital context.
• Personal Responsibility: The bill maintains the idea that individuals choose to submit their genetic information, but it acknowledges that once shared, individuals realistically lack the tools to protect that information from sophisticated foreign exploitation. Therefore, the bill shifts some responsibility to companies and research institutions, requiring them to secure data and certify compliance annually. This introduces a slight move away from pure personal responsibility in favor of structural safeguards, reflecting a belief that collective action is needed to defend individuals from risks they cannot meaningfully manage alone.
• Free Enterprise: The bill restricts free enterprise by banning the use of genome sequencers and software developed by foreign adversaries and requiring U.S.-based data storage for genomic information. While this limits market choices for businesses in biotech, medical, and research sectors, the restrictions are narrowly focused on protecting national security and individual privacy. This is a minor and targeted limitation, justified by the extraordinary sensitivity of genetic data, rather than a broad encroachment on market freedom.
• Private Property Rights: The bill reinforces the principle that individuals have ownership over their genetic information, even after sharing it with medical or research institutions. By requiring that genetic data stay secured within the United States and be protected from adversary countries, the legislation treats genetic data as a form of personal property deserving legal protection. In doing so, it aligns closely with the view that private property — including intangible property like personal data — must be shielded from unauthorized seizure, misuse, or exploitation.
• Limited Government: The bill does slightly expand the role of the Attorney General by authorizing investigation and enforcement actions against violators. However, it does not create any new government agencies, new permanent bureaucracies, or new taxes. The expansion is tightly tied to the enforcement of the narrowly defined genetic information protections. Thus, while there is a modest growth of government authority, it is carefully limited to areas where private actors alone may be unable to prevent significant harm from foreign threats.

• SB 2429 (Same As)